| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Isabel R K Kuebler, Youxi Liu, Bárbara S Bueno Álvarez, Noah M Huber, Joshua A Jolton, Raaga Dasari, Ken T Wakabayash. Melanin-concentrating hormone receptor antagonism differentially attenuates nicotine experience-dependent locomotor behavior in female and male rats. Pharmacology, biochemistry, and behavior. 2023-10-04. PMID:37793486. |
nicotine is a significant public health concern because it is the primary pharmacological agent in tobacco use disorder. |
2023-10-04 |
2023-10-07 |
rat |
| Dara G Ghahremani, Jean-Baptiste F Pochon, Maylen Perez Diaz, Rachel F Tyndale, Andy C Dean, Edythe D Londo. Nicotine dependence and insula subregions: functional connectivity and cue-induced activation. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2023-03-03. PMID:36869233. |
nicotine dependence is a major predictor of relapse in people with tobacco use disorder (tud). |
2023-03-03 |
2023-08-14 |
human |
| Anna Grunze, Sergey Mosolov, Heinz Grunze, Christoph Bor. The detrimental effects of smoking on the course and outcome in adults with bipolar disorder-A narrative review. Frontiers in psychiatry. vol 13. 2023-01-26. PMID:36699491. |
this narrative review highlights the epidemiology, consequences and treatment options of tobacco use disorder (tud) and nicotine dependence (nd) in people with bipolar disorder (bd). |
2023-01-26 |
2023-08-14 |
Not clear |
| Veronica Lunerti, Hongwu Li, Federica Benvenuti, Qianwei Shen, Ana Domi, Laura Soverchia, Rita Maria Concetta Di Martino, Giovanni Bottegoni, Carolina L Haass-Koffler, Nazzareno Cannell. The multitarget FAAH inhibitor/D3 partial agonist ARN15381 decreases nicotine self-administration in male rats. European journal of pharmacology. 2022-06-11. PMID:35690082. |
our data indicates that the concomitant faah inhibition and drd3 partial agonism produced by arn15381 is key to the observed reduction of nicotine self-administration, demonstrating that a multitarget approach may hold clinical importance for the treatment of tobacco use disorder. |
2022-06-11 |
2023-08-14 |
rat |
| Baris Sancak, Gizem Dokuzlu, Ozan Özcan, Urun Ozer Agirba. Self-treatment attempt of tobacco use disorder with Journal of addictive diseases. 2022-05-13. PMID:35550004. |
self-treatment attempt of tobacco use disorder with in the treatment of tobacco use disorder, current approaches focus on pharmacotherapy, nicotine replacement, and psychotherapy. |
2022-05-13 |
2023-08-13 |
human |
| Dvora Shmulewitz, Eliana Greenstein, Malka Stohl, David S Fink, Stephanie Roncone, Claire Walsh, Efrat Aharonovich, Deborah S Hasi. Validity of the DSM-5 tobacco use disorder diagnostics in adults with problematic substance use. Drug and alcohol dependence. vol 234. 2022-03-26. PMID:35338898. |
dsm-5 tobacco use disorder (tud) nosology differs from dsm-iv nicotine dependence (nd) by including craving and dsm-iv abuse criteria, a lower threshold (≥ 2 criteria), and severity levels (mild; moderate; severe). |
2022-03-26 |
2023-08-13 |
Not clear |
| Thiago P Fernandes, Milena E C Oliveira, Gabriella M Silva, Natanael A Santo. Improvement in visual performance after nicotine gum administration in tobacco use disorder: a case report. Journal of addictive diseases. 2022-03-10. PMID:35264083. |
improvement in visual performance after nicotine gum administration in tobacco use disorder: a case report. |
2022-03-10 |
2023-08-13 |
Not clear |
| Lauren Wills, Jessica L Ables, Kevin M Braunscheidel, Stephanie P B Caligiuri, Karim S Elayouby, Clementine Fillinger, Masago Ishikawa, Janna K Moen, Paul J Kenn. Neurobiological Mechanisms of Nicotine Reward and Aversion. Pharmacological reviews. vol 74. issue 1. 2022-01-12. PMID:35017179. |
nachrs also regulate the aversive properties of nicotine, sensitivity to which decreases tobacco use and protects against tobacco use disorder. |
2022-01-12 |
2023-08-13 |
Not clear |
| Soheil Bagheri, Ahmad Reza Saghazade, Samira Abbaszadeh-Mashkani, Hamid Reza Banafshe, Fatemeh Sadat Ghoreishi, Azam Mesdaghinia, Amir Ghader. The effect of vitamin D supplementation on tobacco-related disorders in individuals with a tobacco use disorder: a randomized clinical trial. Journal of addictive diseases. 2021-12-28. PMID:34962457. |
this study evaluated the effects of vitamin d on mental health symptoms, nicotine misuse, and biomarkers of metabolic diseases in individuals with a tobacco use disorder. |
2021-12-28 |
2023-08-13 |
human |
| Michele Fornaro, Andre F Carvalho, Michele De Prisco, Anna Maria Mondin, Martina Billeci, Peter Selby, Felice Iasevoli, Michael Berk, David Jonathan Castle, Andrea de Bartolomei. The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis. Neuroscience and biobehavioral reviews. vol 132. 2021-12-11. PMID:34838527. |
the prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: systematic review and meta-analysis. |
2021-12-11 |
2023-08-13 |
human |
| Michele Fornaro, Andre F Carvalho, Michele De Prisco, Anna Maria Mondin, Martina Billeci, Peter Selby, Felice Iasevoli, Michael Berk, David Jonathan Castle, Andrea de Bartolomei. The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis. Neuroscience and biobehavioral reviews. vol 132. 2021-12-11. PMID:34838527. |
the prevalence, correlates, and management of tobacco use disorder (tud) or nicotine dependence (nd) among people with severe mental illness (smi), namely schizophrenia, bipolar disorder (bd), and major depressive disorder (mdd), remain unclear. |
2021-12-11 |
2023-08-13 |
human |
| Stephen R Baldassarri, Lorig K Kachadourian, Irina Esterlis, Robert H Pietrza. Nicotine Dependence in US Military Veterans: Results from the National Health and Resilience in Veterans Study. Addiction research & theory. vol 28. issue 2. 2021-11-11. PMID:32952489. |
veterans are a unique population that may be at increased risk of tobacco use disorder and nicotine dependence (nd). |
2021-11-11 |
2023-08-13 |
Not clear |
| Michael D Raleigh, Nicola Beltraminelli, Stephanie Fallot, Mark G LeSage, Amy Saykao, Paul R Pentel, Steve Fuller, Thomas Thisted, Zuzanna Biesova, Stephen Horrigan, Darryl Sampey, Bin Zhou, Matthew W Kalni. Attenuating nicotine's effects with high affinity human anti-nicotine monoclonal antibodies. PloS one. vol 16. issue 7. 2021-11-03. PMID:34329335. |
use of nicotine-specific monoclonal antibodies (mabs) to sequester and reduce nicotine distribution to brain has been proposed as a therapeutic approach to treat nicotine addiction (the basis of tobacco use disorder). |
2021-11-03 |
2023-08-13 |
human |
| Andrea H Weinberger, Marc L Steinberg, Sarah D Mills, Sarah S Dermody, Jaimee L Heffner, Amanda Y Kong, Raina D Pang, Rachel L Rose. Assessing sex, gender identity, sexual orientation, race, ethnicity, socioeconomic status, and mental health concerns in tobacco use disorder treatment research: Measurement challenges and recommendations from a Society for Research on Nicotine and Tobacco (SRNT) pre-conference workshop. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2021-10-08. PMID:34622932. |
assessing sex, gender identity, sexual orientation, race, ethnicity, socioeconomic status, and mental health concerns in tobacco use disorder treatment research: measurement challenges and recommendations from a society for research on nicotine and tobacco (srnt) pre-conference workshop. |
2021-10-08 |
2023-08-13 |
Not clear |
| Amanda M Palmer, Benjamin A Toll, Matthew J Carpenter, Eric C Donny, Dorothy K Hatsukami, Alana M Rojewski, Tracy T Smith, Mehmet Sofuoglu, Johannes Thrul, Neal L Benowit. Reappraising Choice in Addiction: Novel Conceptualizations and Treatments for Tobacco Use Disorder. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2021-10-05. PMID:34270729. |
the introduction of alternative nicotine and tobacco products (such as e-cigarettes, heat-not-burn devices, nicotine pouches) warrants an updated framework from which to conceptualize tobacco use disorder (tud). |
2021-10-05 |
2023-08-13 |
Not clear |
| Adria Zern, Michael Seserman, Heather Dacus, Barbara Wallace, Susan Friedlander, Marc W Manseau, Maxine M Smalling, Thomas E Smith, Jill M Williams, Michael T Compto. Screening and Treatment of Tobacco Use Disorder in Mental Health Clinics in New York State: Current Status and Potential Next Steps. Community mental health journal. vol 57. issue 6. 2021-08-09. PMID:33083939. |
one-third of clinics were not providing individual counseling for tobacco use disorder, 39% were not prescribing nicotine replacement therapy, and nearly half reported not prescribing bupropion or varenicline. |
2021-08-09 |
2023-08-13 |
Not clear |
| Matthew Buckli. A 5-Factor Framework for Assessing Tobacco Use Disorder. Tobacco use insights. vol 14. 2021-03-16. PMID:33716514. |
evidence from research on nicotine and tobacco suggests that tobacco use disorder is a complex, and multifactorial condition. |
2021-03-16 |
2023-08-13 |
Not clear |
| Casey Anne Cole, Shannon Powers, Rachel L Tomko, Brett Froeliger, Homayoun Valafa. Quantification of Smoking Characteristics Using Smartwatch Technology: Pilot Feasibility Study of New Technology. JMIR formative research. vol 5. issue 2. 2021-02-25. PMID:33544083. |
while there have been many technological advances in studying the neurobiological and clinical basis of tobacco use disorder and nicotine addiction, there have been relatively minor advances in technologies for monitoring, characterizing, and intervening to prevent smoking in real time. |
2021-02-25 |
2023-08-13 |
Not clear |
| Sarah C Akerman, Mary F Brunette, Douglas L Noordsy, Alan I Gree. Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders. Current addiction reports. vol 1. issue 4. 2020-09-29. PMID:27226947. |
randomized, controlled trials provide some support for use of the atypical antipsychotic clozapine for co-occurring cannabis use disorder, naltrexone and disulfiram for alcohol use disorder, and also nicotine replacement therapy, sustained-release bupropion and varenicline for tobacco use disorder. |
2020-09-29 |
2023-08-13 |
Not clear |
| Xiaoyu Ding, Betty Jo Salmeron, Jamei Wang, Yihong Yang, Elliot A Stein, Thomas J Ros. Evidence of subgroups in smokers as revealed in clinical measures and evaluated by neuroimaging data: a preliminary study. Addiction biology. vol 24. issue 4. 2020-07-14. PMID:29516603. |
to date, fractionation of the nicotine addiction phenotype has been limited to that based primarily on characteristics of cigarette use, although it is widely appreciated that a variety of individual factors are associated with tobacco use disorder. |
2020-07-14 |
2023-08-13 |
Not clear |